Suppr超能文献

表皮生长因子受体(EGFR)的非配体依赖性二聚体形成是一个与配体诱导的EGFR信号传导可分离的步骤。

Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.

作者信息

Yu Xiaochun, Sharma Kailash D, Takahashi Tsuyoshi, Iwamoto Ryo, Mekada Eisuke

机构信息

Institute of Life Science, Kurume University, Kurume, Fukuoka 839-0861, Japan.

出版信息

Mol Biol Cell. 2002 Jul;13(7):2547-57. doi: 10.1091/mbc.01-08-0411.

Abstract

Dimerization and phosphorylation of the epidermal growth factor (EGF) receptor (EGFR) are the initial and essential events of EGF-induced signal transduction. However, the mechanism by which EGFR ligands induce dimerization and phosphorylation is not fully understood. Here, we demonstrate that EGFRs can form dimers on the cell surface independent of ligand binding. However, a chimeric receptor, comprising the extracellular and transmembrane domains of EGFR and the cytoplasmic domain of the erythropoietin receptor (EpoR), did not form a dimer in the absence of ligands, suggesting that the cytoplasmic domain of EGFR is important for predimer formation. Analysis of deletion mutants of EGFR showed that the region between (835)Ala and (918)Asp of the EGFR cytoplasmic domain is required for EGFR predimer formation. In contrast to wild-type EGFR ligands, a mutant form of heparin-binding EGF-like growth factor (HB2) did not induce dimerization of the EGFR-EpoR chimeric receptor and therefore failed to activate the chimeric receptor. However, when the dimerization was induced by a monoclonal antibody to EGFR, HB2 could activate the chimeric receptor. These results indicate that EGFR can form a ligand-independent inactive dimer and that receptor dimerization and activation are mechanistically distinct and separable events.

摘要

表皮生长因子(EGF)受体(EGFR)的二聚化和磷酸化是EGF诱导信号转导的初始且关键的事件。然而,EGFR配体诱导二聚化和磷酸化的机制尚未完全阐明。在此,我们证明EGFR可在细胞表面形成不依赖配体结合的二聚体。然而,一种嵌合受体,由EGFR的胞外和跨膜结构域以及促红细胞生成素受体(EpoR)的胞质结构域组成,在无配体时未形成二聚体,这表明EGFR的胞质结构域对预二聚体形成很重要。对EGFR缺失突变体的分析表明,EGFR胞质结构域中(835)丙氨酸和(918)天冬氨酸之间的区域是EGFR预二聚体形成所必需的。与野生型EGFR配体不同,肝素结合表皮生长因子样生长因子(HB2)的突变形式未诱导EGFR - EpoR嵌合受体的二聚化,因此未能激活该嵌合受体。然而,当通过抗EGFR单克隆抗体诱导二聚化时,HB2可激活该嵌合受体。这些结果表明,EGFR可形成不依赖配体的无活性二聚体,并且受体二聚化和激活在机制上是不同且可分离的事件。

相似文献

2
Epidermal growth factor receptor (EGFR) signaling in cancer.
Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27.
3
Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
Biochemistry. 2011 May 10;50(18):3581-90. doi: 10.1021/bi101785h. Epub 2011 Apr 15.
4
Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor.
Biochemistry. 2005 Nov 15;44(45):14920-31. doi: 10.1021/bi050751j.
5
Structure-function studies of ligand-induced epidermal growth factor receptor dimerization.
Biochemistry. 1998 Apr 7;37(14):4884-91. doi: 10.1021/bi972548x.
6
Heparin-binding epidermal growth factor cleavage mediates zinc-induced epidermal growth factor receptor phosphorylation.
Am J Respir Cell Mol Biol. 2004 Apr;30(4):540-7. doi: 10.1165/rcmb.2003-0233OC. Epub 2003 Sep 11.
8
Single-molecule imaging of EGFR signalling on the surface of living cells.
Nat Cell Biol. 2000 Mar;2(3):168-72. doi: 10.1038/35004044.
10
Ligand binding induces a conformational change in epidermal growth factor receptor dimers.
Growth Factors. 2012 Dec;30(6):394-409. doi: 10.3109/08977194.2012.739619. Epub 2012 Nov 20.

引用本文的文献

1
Targeting Molecular Pathways in Breast Cancer Using Plant-Derived Bioactive Compounds: A Comprehensive Review.
J Exp Pharmacol. 2025 Jun 22;17:375-401. doi: 10.2147/JEP.S528132. eCollection 2025.
3
An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung Tumorigenesis.
Adv Sci (Weinh). 2025 May;12(20):e2413443. doi: 10.1002/advs.202413443. Epub 2025 Mar 31.
4
Cancer and Secretomes: HLA-G and Cancer Puzzle.
Adv Exp Med Biol. 2025;1479:165-179. doi: 10.1007/5584_2024_843.
5
The Agonistic Activity of the Human Epidermal Growth Factor is Reduced by the D46G Substitution.
Protein Pept Lett. 2024;31(7):504-518. doi: 10.2174/0109298665297321240708044223.
6
EGFR is a potential dual molecular target for cancer and Alzheimer's disease.
Front Pharmacol. 2023 Aug 2;14:1238639. doi: 10.3389/fphar.2023.1238639. eCollection 2023.
7
ErbBs in Lens Cell Fibrosis and Secondary Cataract.
Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):6. doi: 10.1167/iovs.64.10.6.
8
Budding uninhibited by benzimidazoles-1 (BUB1) regulates EGFR signaling by reducing EGFR internalization.
Aging (Albany NY). 2023 Jul 3;15(13):6011-6030. doi: 10.18632/aging.204820.

本文引用的文献

1
Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain.
J Mol Biol. 2001 Aug 31;311(5):1011-26. doi: 10.1006/jmbi.2001.4923.
2
Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain.
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4379-84. doi: 10.1073/pnas.081069198.
3
Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.
Mol Biol Cell. 2000 Oct;11(10):3589-99. doi: 10.1091/mbc.11.10.3589.
4
Single-molecule imaging of EGFR signalling on the surface of living cells.
Nat Cell Biol. 2000 Mar;2(3):168-72. doi: 10.1038/35004044.
6
Receptor signaling: when dimerization is not enough.
Curr Biol. 1999;9(15):R568-71. doi: 10.1016/s0960-9822(99)80357-1.
9
The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands.
Biochim Biophys Acta. 1998 Feb 20;1377(1):M25-37. doi: 10.1016/s0304-419x(97)00032-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验